Payment overview · 2025
General Payments
$23.96
1 reported records · 1 companies
Healthcare provider profile · identity verified
Pramod Kakarala, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · ATLANTA, GA · NPI 1972881795
Verified facts
What the public records show
CMS Open Payments records show Pramod Kakarala, M.D. received $23.96 in general payments during 2025 across 1 reported records.
PFIZER INC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Eliquis.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 852 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| PFIZER INC. | Unresolved — no canonical attribution shown | $23.96 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $23.96 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ELIQUIS Normalized: eliquis |
Drug | PFIZER INC. | $23.96 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| ELIQUIS eliquis |
2025 | Eliquis | 2024 | 852 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
852 | 89 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 1710 | 110 |
| Famotidine | Famotidine | 1512 | 80 |
| Amlodipine Besylate | Amlodipine Besylate | 1280 | 99 |
| Sertraline Hcl | Sertraline Hcl | 1060 | 72 |
| Gabapentin | Gabapentin | 988 | 95 |
| Potassium Chloride | Potassium Chloride | 935 | 75 |
| Memantine Hcl | Memantine Hcl | 911 | 45 |
| Furosemide | Furosemide | 877 | 93 |
| Eliquis | Apixaban | 852 | 89 |
| Pravastatin Sodium | Pravastatin Sodium | 789 | 93 |
| Omeprazole | Omeprazole | 762 | 110 |
| Metoprolol Tartrate | Metoprolol Tartrate | 752 | 68 |
| Atorvastatin Calcium | Atorvastatin Calcium | 734 | 101 |
| Donepezil Hcl | Donepezil Hcl | 727 | 48 |
| Metoprolol Succinate | Metoprolol Succinate | 716 | 69 |
| Quetiapine Fumarate | Quetiapine Fumarate | 651 | 40 |
| Trazodone Hcl | Trazodone Hcl | 648 | 45 |
| Divalproex Sodium | Divalproex Sodium | 574 | 23 |
| Lisinopril | Lisinopril | 520 | 47 |
| Metformin Hcl | Metformin Hcl | 510 | 36 |
| Valsartan | Valsartan | 507 | 52 |
| Mirtazapine | Mirtazapine | 488 | 32 |
| Tamsulosin Hcl | Tamsulosin Hcl | 471 | 58 |
| Montelukast Sodium | Montelukast Sodium | 460 | 38 |
| Escitalopram Oxalate | Escitalopram Oxalate | 420 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 396 | 39 |
| Buspirone Hcl | Buspirone Hcl | 344 | 26 |
| Pantoprazole Sodium | Pantoprazole Sodium | 283 | 44 |
| Fenofibrate | Fenofibrate Nanocrystallized | 250 | 15 |
| Clopidogrel | Clopidogrel Bisulfate | 243 | 38 |
| Risperidone | Risperidone | 230 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 219 | 17 |
| Amiodarone Hcl | Amiodarone Hcl | 214 | 31 |
| Midodrine Hcl | Midodrine Hcl | 206 | 29 |
| Tradjenta | Linagliptin | 196 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 190 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 180 | 16 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 178 | suppressed |
| Carvedilol | Carvedilol | 178 | 33 |
| Allopurinol | Allopurinol | 169 | 16 |
| Xarelto | Rivaroxaban | 166 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 162 | 19 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 160 | 37 |
| Torsemide | Torsemide | 151 | 21 |
| Sucralfate | Sucralfate | 149 | suppressed |
| Glipizide | Glipizide | 148 | 13 |
| Levetiracetam | Levetiracetam | 147 | 12 |
| Lorazepam | Lorazepam | 145 | 31 |
| Insulin Aspart Flexpen | Insulin Aspart | 133 | 59 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 132 | suppressed |
| Jardiance | Empagliflozin | 128 | 13 |
| Ezetimibe | Ezetimibe | 126 | 15 |
| Olanzapine | Olanzapine | 126 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 126 | 54 |
| Atenolol | Atenolol | 125 | 11 |
| Hydrochlorothiazide | Hydrochlorothiazide | 123 | suppressed |
| Entresto | Sacubitril/Valsartan | 122 | 12 |
| Aripiprazole | Aripiprazole | 117 | 12 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 115 | 20 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 115 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 114 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 111 | 64 |
| Bumetanide | Bumetanide | 107 | suppressed |
| Baclofen | Baclofen | 103 | 11 |
| Oxybutynin Chloride | Oxybutynin Chloride | 102 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 100 | 38 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 97 | 52 |
| Levemir Flexpen | Insulin Detemir | 96 | 17 |
| Methenamine Hippurate | Methenamine Hippurate | 91 | suppressed |
| Finasteride | Finasteride | 90 | 13 |
| Albuterol Sulfate | Albuterol Sulfate | 89 | 13 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 88 | 64 |
| Bupropion Hcl Sr | Bupropion Hcl | 88 | 11 |
| Calcitriol | Calcitriol | 85 | suppressed |
| Dropsafe Pen Needle | Pen Needle, Diabetic, Safety | 85 | 35 |
| Farxiga | Dapagliflozin Propanediol | 84 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 83 | suppressed |
| Prednisone | Prednisone | 81 | 20 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 79 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 76 | 24 |
| Metolazone | Metolazone | 75 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 72 | 17 |
| Lamotrigine | Lamotrigine | 72 | suppressed |
| Spironolactone | Spironolactone | 70 | 21 |
| Carbamazepine | Carbamazepine | 67 | suppressed |
| Digoxin | Digoxin | 67 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 66 | 37 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 66 | 17 |
| Warfarin Sodium | Warfarin Sodium | 65 | suppressed |
| Meloxicam | Meloxicam | 64 | suppressed |
| Topiramate | Topiramate | 63 | suppressed |
| Bupropion Xl | Bupropion Hcl | 60 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 56 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 55 | 14 |
| Lubiprostone | Lubiprostone | 53 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 51 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 50 | 12 |
| Simvastatin | Simvastatin | 50 | suppressed |
| Methotrexate | Methotrexate Sodium | 49 | suppressed |
| Nifedipine Er | Nifedipine | 49 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 48 | 11 |
| Alprazolam | Alprazolam | 47 | 17 |
| Haloperidol | Haloperidol | 47 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 47 | 31 |
| Unifine Safecontrol Pen Needle | Pen Needle,dual Safety,diabetc | 46 | 22 |
| Nitroglycerin | Nitroglycerin | 45 | 41 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 45 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 44 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 44 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 43 | 11 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 43 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 43 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 42 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 42 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 39 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 39 | suppressed |
| Cephalexin | Cephalexin | 38 | 26 |
| Cinacalcet Hcl | Cinacalcet Hcl | 38 | suppressed |
| Latanoprost | Latanoprost | 38 | 14 |
| Pioglitazone Hcl | Pioglitazone Hcl | 38 | suppressed |
| Colchicine | Colchicine | 37 | suppressed |
| Losartan Potassium | Losartan Potassium | 36 | 14 |
| Alendronate Sodium | Alendronate Sodium | 35 | 13 |
| Januvia | Sitagliptin Phosphate | 35 | suppressed |
| Pregabalin | Pregabalin | 35 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 35 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 34 | 15 |
| Letrozole | Letrozole | 34 | suppressed |
| Nystatin | Nystatin | 34 | 14 |
| Brilinta | Ticagrelor | 33 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 33 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 33 | suppressed |
| Glimepiride | Glimepiride | 31 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 30 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 30 | suppressed |
| Ibuprofen | Ibuprofen | 29 | suppressed |
| Chlorthalidone | Chlorthalidone | 28 | suppressed |
| Lactulose | Lactulose | 28 | suppressed |
| Glipizide Er | Glipizide | 27 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 27 | suppressed |
| Dexamethasone | Dexamethasone | 26 | suppressed |
| Perphenazine | Perphenazine | 26 | suppressed |
| Novolog Flexpen | Insulin Aspart | 25 | 14 |
| Vraylar | Cariprazine Hcl | 25 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 24 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 23 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 23 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 22 | 14 |
| Pentoxifylline | Pentoxifylline | 22 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 22 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 20 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 20 | suppressed |
| Roflumilast | Roflumilast | 20 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 19 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 18 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 18 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 18 | suppressed |
| Novolog | Insulin Aspart | 18 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 18 | suppressed |
| Ketoconazole | Ketoconazole | 17 | 11 |
| Primidone | Primidone | 17 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 16 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 15 | suppressed |
| Folic Acid | Folic Acid | 15 | suppressed |
| Methocarbamol | Methocarbamol | 15 | 15 |
| Phenobarbital | Phenobarbital | 15 | suppressed |
| Rexulti | Brexpiprazole | 15 | suppressed |
| Trospium Chloride Er | Trospium Chloride | 15 | suppressed |
| Azithromycin | Azithromycin | 14 | 13 |
| Clonazepam | Clonazepam | 14 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 14 | 13 |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 14 | suppressed |
| Cefdinir | Cefdinir | 13 | 13 |
| Celecoxib | Celecoxib | 13 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 13 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 13 | suppressed |
| Tiadylt Er | Diltiazem Hcl | 13 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 12 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 12 | suppressed |
| Irbesartan | Irbesartan | 12 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 12 | suppressed |
| Cyclosporine | Cyclosporine | 11 | suppressed |
| Ertapenem | Ertapenem Sodium | 11 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $23.96 · 1 records | PFIZER INC. | ELIQUIS | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Eliquis play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with PFIZER INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error